default author photo

Jessica Fulgencio

affiliation not provided to SSRN

Romark Laboratories, L.C. - Romark Institute of Medical Research

Tampa, FL

United States

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

55

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Early Treatment With Nitazoxanide Prevents Worsening of Mild and Moderate COVID-19 and Subsequent Hospitalization

Number of pages: 19 Posted: 06 Oct 2021
Jean-Francois Rossignol, Matthew Bardin, Matthew Bardin, Jessica Fulgencio, Jessica Fulgencio, Dena Mogelnicki, Dena Mogelnicki, Christian Brechot and Vanguard Study Group
Romark Laboratories, L.C. - Romark Institute of Medical Research, affiliation not provided to SSRNRomark Laboratories, L.C. - Romark Institute of Medical Research, affiliation not provided to SSRNRomark Laboratories, L.C. - Romark Institute of Medical Research, affiliation not provided to SSRNRomark Laboratories, L.C. - Romark Institute of Medical Research, University of South Florida - College of Medicine and affiliation not provided to SSRN
Downloads 55 (1,020,567)
Citation 1

Abstract:

Loading...

Covid-19, Nitazoxanide, Respiratory Infection, Antiviral, SARS-CoV-2